Literature DB >> 25380138

European society of contraception statement on contraception in obese women.

Gabriele S Merki-Feld1, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci, Regine Sitruk-Ware.   

Abstract

The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

Entities:  

Keywords:  Contraceptive failure; Depo-medroxyprogesterone; Efficacy; Hormonal contraception; Obesity; Progestin-only contraception; Thromboembolic risk; Weight

Mesh:

Substances:

Year:  2014        PMID: 25380138     DOI: 10.3109/13625187.2014.960561

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  8 in total

1.  Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery.

Authors:  Michiel A Damhof; Esther Pierik; Lisanne L Krens; Marloes Vermeer; Marc J van Det; Eric N van Roon
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

Review 2.  Clinical Practice Guidelines for Childbearing Female Candidates for Bariatric Surgery, Pregnancy, and Post-partum Management After Bariatric Surgery.

Authors:  Cécile Ciangura; Muriel Coupaye; Philippe Deruelle; Géraldine Gascoin; Daniela Calabrese; Emmanuel Cosson; Guillaume Ducarme; Bénédicte Gaborit; Bénédicte Lelièvre; Laurent Mandelbrot; Niccolo Petrucciani; Didier Quilliot; Patrick Ritz; Geoffroy Robin; Agnès Sallé; Jean Gugenheim; Jacky Nizard
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

Review 3.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; Alissa Bernholc; Mario Chen; Thomas W Grey; Conrad Otterness; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-18

4.  Review: Sex-Specific Aspects in the Bariatric Treatment of Severely Obese Women.

Authors:  Pia Jäger; Annina Wolicki; Johannes Spohnholz; Metin Senkal
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

5.  Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.

Authors:  Charlotte Ginstman; Helena Kopp Kallner; Johanna Fagerberg-Silwer; Björn Carlsson; Andreas Ärlemalm; Ylva Böttiger; Jan Brynhildsen
Journal:  Obes Surg       Date:  2020-06       Impact factor: 4.129

Review 6.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28

Review 7.  Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery.

Authors:  Clarissa Lam; Amitasrigowri S Murthy
Journal:  Open Access J Contracept       Date:  2016-09-29

8.  Contraceptive Options Following Gestational Diabetes: Current Perspectives.

Authors:  Ashley M Turner; Emily A Donelan; Jessica W Kiley
Journal:  Open Access J Contracept       Date:  2019-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.